117 related articles for article (PubMed ID: 1648697)
1. The role of contraception in the development of postmolar gestational trophoblastic tumor.
Deicas RE; Miller DS; Rademaker AW; Lurain JR
Obstet Gynecol; 1991 Aug; 78(2):221-6. PubMed ID: 1648697
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives and postmolar trophoblastic disease.
Berkowitz RS; Goldstein DP; Marean AR; Bernstein M
Obstet Gynecol; 1981 Oct; 58(4):474-7. PubMed ID: 6269038
[TBL] [Abstract][Full Text] [Related]
3. Postmolar trophoblastic disease in women using hormonal contraception with and without estrogen.
Eddy GL; Schlaerth JB; Nalick RH; Gaddis O; Nakamura RM; Morrow CP
Obstet Gynecol; 1983 Dec; 62(6):736-40. PubMed ID: 6633999
[TBL] [Abstract][Full Text] [Related]
4. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
[TBL] [Abstract][Full Text] [Related]
5. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
[TBL] [Abstract][Full Text] [Related]
6. Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center.
Lurain JR; Brewer JI; Torok EE; Halpern B
Obstet Gynecol; 1982 Sep; 60(3):354-60. PubMed ID: 6289207
[TBL] [Abstract][Full Text] [Related]
7. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
[TBL] [Abstract][Full Text] [Related]
8. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
9. The risk factors in the development of persistent trophoblastic disease following hydatidiform mole.
Tangtrakul S; Srisupundit S; Linasmita V; Bullangpoti S; Bhamarapravati Y
J Med Assoc Thai; 1990 Feb; 73 Suppl 1():33-6. PubMed ID: 2161897
[TBL] [Abstract][Full Text] [Related]
10. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
11. Hydatidiform mole: clinicopathologic associations with the development of postevacuation trophoblastic disease.
Murad TM; Longley JV; Lurain JR; Brewer JI
Int J Gynaecol Obstet; 1990 Aug; 32(4):359-67. PubMed ID: 1977631
[TBL] [Abstract][Full Text] [Related]
12. [Gestational trophoblastic tumors and recent clinical information].
Shimizu T; Yaegashi N
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
[TBL] [Abstract][Full Text] [Related]
13. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut.
Kohorn EI
Obstet Gynecol; 1982 Jan; 59(1):78-84. PubMed ID: 6281702
[TBL] [Abstract][Full Text] [Related]
14. Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life.
Bandy LC; Clarke-Pearson DL; Hammond CB
Obstet Gynecol; 1984 Sep; 64(3):395-9. PubMed ID: 6087230
[TBL] [Abstract][Full Text] [Related]
15. Subsequent reproductive experience after treatment for gestational trophoblastic disease.
Kim JH; Park DC; Bae SN; Namkoong SE; Kim SJ
Gynecol Oncol; 1998 Oct; 71(1):108-12. PubMed ID: 9784329
[TBL] [Abstract][Full Text] [Related]
16. Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease.
Gaffield ME; Kapp N; Curtis KM
Contraception; 2009 Oct; 80(4):363-71. PubMed ID: 19751859
[TBL] [Abstract][Full Text] [Related]
17. Predictors of persistent disease in women with complete hydatidiform mole.
Ayhan A; Tuncer ZS; Halilzade H; Küçükali T
J Reprod Med; 1996 Aug; 41(8):591-4. PubMed ID: 8866387
[TBL] [Abstract][Full Text] [Related]
18. Repeat gestational trophoblastic disease.
Sand PK; Lurain JR; Brewer JI
Obstet Gynecol; 1984 Feb; 63(2):140-4. PubMed ID: 6320076
[TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
20. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]